1. Home
  2. RMCO vs TSBX Comparison

RMCO vs TSBX Comparison

Compare RMCO & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMCO
  • TSBX
  • Stock Information
  • Founded
  • RMCO 2021
  • TSBX 2015
  • Country
  • RMCO United States
  • TSBX United States
  • Employees
  • RMCO N/A
  • TSBX N/A
  • Industry
  • RMCO Multi-Sector Companies
  • TSBX
  • Sector
  • RMCO Miscellaneous
  • TSBX
  • Exchange
  • RMCO Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • RMCO 14.9M
  • TSBX 12.3M
  • IPO Year
  • RMCO N/A
  • TSBX 2023
  • Fundamental
  • Price
  • RMCO $1.08
  • TSBX $0.44
  • Analyst Decision
  • RMCO
  • TSBX Buy
  • Analyst Count
  • RMCO 0
  • TSBX 3
  • Target Price
  • RMCO N/A
  • TSBX $4.75
  • AVG Volume (30 Days)
  • RMCO 44.3K
  • TSBX 153.9K
  • Earning Date
  • RMCO 01-31-2025
  • TSBX 11-12-2024
  • Dividend Yield
  • RMCO N/A
  • TSBX N/A
  • EPS Growth
  • RMCO N/A
  • TSBX N/A
  • EPS
  • RMCO N/A
  • TSBX N/A
  • Revenue
  • RMCO $695,792.00
  • TSBX N/A
  • Revenue This Year
  • RMCO N/A
  • TSBX N/A
  • Revenue Next Year
  • RMCO N/A
  • TSBX N/A
  • P/E Ratio
  • RMCO N/A
  • TSBX N/A
  • Revenue Growth
  • RMCO 46.15
  • TSBX N/A
  • 52 Week Low
  • RMCO $0.70
  • TSBX $0.40
  • 52 Week High
  • RMCO $1.80
  • TSBX $5.75
  • Technical
  • Relative Strength Index (RSI)
  • RMCO 55.01
  • TSBX 40.57
  • Support Level
  • RMCO $0.96
  • TSBX $0.41
  • Resistance Level
  • RMCO $1.04
  • TSBX $0.62
  • Average True Range (ATR)
  • RMCO 0.07
  • TSBX 0.06
  • MACD
  • RMCO 0.00
  • TSBX -0.01
  • Stochastic Oscillator
  • RMCO 89.30
  • TSBX 14.15

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: